CalciMedica (CALC) Insider Trading & Ownership $3.45 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CalciMedica (NASDAQ:CALC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage41.55%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$4.63 MNumber OfInsiders Selling(Last 12 Months)0 Get CALC Insider Trade Alerts Want to know when executives and insiders are buying or selling CalciMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CALC Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin CalciMedica Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2024A. Rachel LehenyCEOBuy20,000$3.75$75,000.00 11/1/2024Eric W RobertsInsiderBuy53,333$3.75$199,998.75 11/1/2024Fred A MiddletonDirectorBuy87,744$3.75$329,040.00 11/1/2024Sanderling Venture Partners ViMajor ShareholderBuy86,867$3.75$325,751.25 8/27/2024A. Rachel LehenyCEOBuy1,000$4.19$4,190.00 8/23/2024Eric W RobertsInsiderBuy5,000$3.57$17,850.00 2025: Digital Asset Insights You Need to Know (Ad)Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today!8/23/2024Robert N WilsonDirectorBuy54,000$3.72$200,880.00 8/21/2024Eric W RobertsInsiderBuy5,000$4.04$20,200.00 6/27/2024Eric W RobertsInsiderBuy5,000$3.22$16,100.00 6/27/2024Robert N WilsonDirectorBuy8,443$3.23$27,270.89 4/1/2024Eric W RobertsInsiderBuy746$3.90$2,909.40 1/23/2024Fred A MiddletonDirectorBuy679,384$3.70$2,513,720.80 1/23/2024Sanderling Venture Partners ViMajor ShareholderBuy243,356$3.70$900,417.20 12/11/2023Robert N WilsonDirectorBuy506$3.30$1,669.80 (Data available from 1/1/2013 forward) CALC Insider Trading Activity - Frequently Asked Questions Who is on CalciMedica's Insider Roster? The list of insiders at CalciMedica includes A. Rachel Leheny, Eric W Roberts, Fred A Middleton, Robert N Wilson, and Sanderling Venture Partners Vi. Learn more on insiders at CALC. What percentage of CalciMedica stock is owned by insiders? 41.55% of CalciMedica stock is owned by insiders. Learn more on CALC's insider holdings. Which CalciMedica insiders have been buying company stock? The following insiders have purchased CALC shares in the last 24 months: A. Rachel Leheny ($101,052.80), Eric W Roberts ($287,649.13), Fred A Middleton ($2,842,760.80), Robert N Wilson ($229,820.69), and Sanderling Venture Partners Vi ($1,226,168.45). How much insider buying is happening at CalciMedica? Insiders have purchased a total of 1,267,605 CALC shares in the last 24 months for a total of $4,687,451.87 bought. CalciMedica Key ExecutivesDr. A. Rachel Leheny Ph.D. (Age 61)CEO & Director Compensation: $852.84kMr. Eric W. Roberts (Age 60)Chief Business Officer & Vice Chairman of the Board Compensation: $757.4k4 recent tradesDr. Kenneth A. Stauderman Ph.D. (Age 71)Co-Founder & Chief Scientific Officer Compensation: $615.59kMr. Michael J. Dunn M.B.A. (Age 68)MBA, President & COO Dr. Anjana Rao Ph.D.Co-Founder and Scientific AdvisorDr. Patrick Hogan Ph.D.Co-Founder and Scientific AdvisorDr. Stefan Feske M.D.Co-Founder and Scientific AdvisorMr. Daniel E. Geffken M.B.A. (Age 67)Interim Chief Financial Officer Cindy ReiedenbergAccountantMr. John M. Dunn J.D. (Age 72)General Counsel More Insider Trading Tools from MarketBeat Related Companies CARA Insider Transactions CRBU Insider Transactions DMAC Insider Transactions ACTU Insider Transactions SCPH Insider Transactions INZY Insider Transactions KYTX Insider Transactions NKTX Insider Transactions GALT Insider Transactions TNYA Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:CALC) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.